Amgen, Inc.

  AMGN 105.62 +0.65 (+0.6%)

Amgen engages in the discovery, development, manufacturing, and the marketing of therapeutic products for humans in the areas of supportative cancer care, nephrology, inflammation, and oncology worldwide.

What do YOU think?

Use the icons below to select how you think AMGN will perform over the next 90 days. Just like you'd suspect, red is bad and green is good.

    Sentiment
  • Spc

    Sentiment

  • Medium

    Activity

Have something to say?

Register for Piqqem
and give us your take on Amgen, Inc.